ALDH1A1 and exocrine pancreatic carcinoma: Thus, targeting AURKA and ALDH1A1 in combination is expected to be highly effective in inhibiting tumorigenesis, chemoresistance, and metastasis in highly lethal pancreatic carcinoma.